Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Non-FDG PET imaging

NCRI

Published: 2 Dec 2009

Views: 15508

Rating:

Save

Dr Stefano Fanti, University of Bologna, Italy

Dr Stefano Fanti, from the Department of Nuclear Medicine, S. Orsola-Malpighi Polyclinic, University of Bologna, Bologna, Italy, talking at NCRI 2009, Birmingham, UK to ecancer Managing Editor Prof Gordon McVie. PET imaging and non-FDG tracers for diagnosing cancers which do not show up with FDG tracers. Carbon 11 Gallium 68 for neuroendocrine tumours.

Related Videos

Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities

Dr Masood Moghul - The Royal Marsden Institute of Cancer Research, London, UK

Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities ( Dr Masood Moghul - The Royal Marsden Institute of Cancer Research, London, UK )

EMUC 2024: Optimising strategies in mHSPC and mCRPC

Prof Gerhardt Attard, Prof Wolfgang Fendler, Dr Lynda Corrigan, Prof Jochen Walz

EMUC 2024: Optimising strategies in mHSPC and mCRPC ( Prof Gerhardt Attard, Prof Wolfgang Fendler, Dr Lynda Corrigan, Prof Jochen Walz )

New classification for identifying HR myeloma based on cytogenetic abnormalities

Dr Jill Corre - IUCT Oncopole, Toulouse, France

New classification for identifying HR myeloma based on cytogenetic abnormalities ( Dr Jill Corre - IUCT Oncopole, Toulouse, France )

Laser oncosurgery - A new perspective in treating cancer

Dr Rusy Bhalla - Orchid Center For Laser Surgery, Mumbai, India

Laser oncosurgery - A new perspective in treating cancer ( Dr Rusy Bhalla - Orchid Center For Laser Surgery, Mumbai, India )

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

Dr Rom Leidner - Providence Cancer Institute, Portland, USA

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation ( Dr Rom Leidner - Providence Cancer Institute, Portland, USA )

Best practice in HRRm testing in patients with metastatic prostate cancer

Prof Martin Schostak, Dr Alexander Wyatt, Prof Charles Ryan and Dr Emmanuel Antonarakis

Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Martin Schostak, Dr Alexander Wyatt, Prof Charles Ryan and Dr Emmanuel Antonarakis )

Adjuvant radiotherapy has no benefit following radical prostatectomy

Prof Noel Clarke - The Christie NHS Foundation Trust, Manchester, UK

Adjuvant radiotherapy has no benefit following radical prostatectomy ( Prof Noel Clarke - The Christie NHS Foundation Trust, Manchester, UK )

The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer

Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina

The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer ( Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina )

Comparative cost-effectiveness of alternative imaging and surveillance schedules for testicular seminoma

Prof Robert Huddart - Royal Marsden NHS Foundation Trust, London, UK

Comparative cost-effectiveness of alternative imaging and surveillance schedules for testicular seminoma ( Prof Robert Huddart - Royal Marsden NHS Foundation Trust, London, UK )

More from ecancer